NYSE:ELPC 28 December 2025

May 2, 2026, 5:12 PM EDT. Tenet Healthcare (THC) is acting as a Capital Compounder by reducing its shares outstanding by 7.9% over the last year. This strategy boosts earnings per share (EPS) growth to 183.6%, outpacing net income annual growth of 168.4%. The stock delivered a 153% price gain over three years, reflecting 36.3% annualized growth. THC generates $4.4 billion in operating cash flow, funding $1 billion capital reinvestment and a 7.6% net shareholder yield through buybacks. Its debt levels remain manageable with a Net Debt/EBITDA ratio of 2.1 and interest coverage at 4.9. THC's 6.5% revenue growth and 17.5% operating margin position it as a resilient business. Investors should consider idiosyncratic risks and integrate THC into diversified strategies for risk management.